Cepef-T 1.125 Injection
Marketer
Ampira Biotechnics Pvt Ltd
Salt Composition
Cefepime (1000mg) + Tazobactum (125mg)
Overview Cepef-T 1.125 Injection
Ceftibuten 1.125mg injection, a dual-antibiotic formulation, combats diverse bacterial infections by inhibiting microbial proliferation. Administered solely under medical guidance, this medication requires adherence to the prescribed schedule; complete the full course regardless of symptom improvement. Potential side effects include nausea, vomiting, diarrhea, and skin rashes; injection site reactions (redness, swelling, pain) are also possible but typically resolve spontaneously. Severe or persistent side effects necessitate immediate medical attention. Allergic reactions (rash, itching, swelling, respiratory distress) demand urgent medical care. Prior to commencing treatment, inform your physician of all current medications and pre-existing conditions. Pregnant or lactating individuals should seek medical counsel before use. Alcohol consumption should be avoided due to the risk of increased drowsiness. While usually non-impairing, driving should be avoided if drowsiness or dizziness occurs.
Primary Ingredients of Cepef-T 1.125 Injection
The provided text is "undefined," therefore no rephrasing is possible.
Uses of Cepef-T 1.125 Injection
Infections caused by bacteria
Major Benefits of Cepef-T 1.125 Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Cepef-T 1.125 Injection:
- Diarrhea
- Increased white blood cell count (eosinophils)
- Injection site phlebitis
- Skin rash
- Increased liver enzymes
- Positive Coombs test
How to use Cepef-T 1.125 Injection:
This medication will be administered by your physician or their designated nurse; self-medication is strictly prohibited.
How Cepef-T 1.125 Injection works:
Cepef-T 1.125 Injection unites Cefepime, an antibiotic, with Tazobactum, a beta-lactamase inhibitor. Cefepime's mechanism involves disrupting bacterial cell wall synthesis, a crucial process for bacterial viability. Tazobactum counteracts bacterial enzymes that would otherwise neutralize Cefepime's effects. This combination improves Cefepime's efficacy by overcoming bacterial resistance.
SAFETY ADVICE
AlcoholCAUTION
It's recommended to avoid alcohol while using Cepef-T 1.125 Injection. Seek medical advice before combining them.
PregnancySAFE IF PRESCRIBED
The injectable medication Cepef-T 1.125 is typically deemed safe for pregnant individuals. Preclinical trials in animals revealed minimal or no harm to the fetus; nevertheless, clinical data from human trials remain scarce.
Breast feedingSAFE IF PRESCRIBED
Cepef-T 1.125 Injection is considered safe for use while breastfeeding. Research in humans indicates minimal drug transfer to breast milk, posing no apparent risk to the infant.
DrivingUNSAFE
Following administration of Cepef-T 1.125 Injection, temporary blurred vision may occur. Refrain from driving until visual acuity returns to normal.
KidneyCAUTION
Caution is advised when administering Cepef-T 1.125 Injection to individuals with impaired renal function. Dosage modification may be necessary. Physician consultation is recommended.
LiverSAFE IF PRESCRIBED
Ceftibuten injection (1.125 g) appears to pose minimal risk for individuals with hepatic impairment. Existing evidence indicates dose modification may be unnecessary; however, physician consultation is recommended.
What if you forget to take Cepef-T 1.125 Injection :
Should you forget a scheduled Cepef-T 1.125 Injection, seek medical advice immediately.
Facts to Know About Cepef-T 1.125 Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Therapy | Infectious Disease Treatments |
3,018 People bought this recently